vimarsana.com
Home
Live Updates
Dr Zhang on the Implications of Findings From the KEYNOTE-56
Dr Zhang on the Implications of Findings From the KEYNOTE-56
Dr Zhang on the Implications of Findings From the KEYNOTE-564 Trial in RCC
Tian Zhang, MD, MHS, discusses the implications of subgroup analyses from the KEYNOTE-564 trial in patients with renal cell carcinoma.
Related Keywords
,
Department Of Internal Medicine ,
Haroldc Simmons Comprehensive Cancer Center ,
International Kidney Cancer Symposium ,
Ut Southwestern Medical Center ,
Tian Zhang ,
Internal Medicine ,
Comprehensive Cancer Center ,
Medical Center ,
Kidney Cancer Symposium ,
Cancers Symposium ,
Ut Southwestern Haroldc Simmons Comprehensive Cancer Center ,
Onclive Tv ,
Genitourinary Cancers ,
Nrcc ,
Renal Cell Carcinoma ,